A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1880-4233
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A risk scoring system based on tumor microenvironment cells to predict prognosis and immune activity in triple-negative breast cancer ; volume:29 ; number:3 ; day:21 ; month:1 ; year:2022 ; pages:468-477 ; date:5.2022
Breast cancer ; 29, Heft 3 (21.1.2022), 468-477, 5.2022
- Urheber
-
Yang, Anli
Wu, Minqing
Ni, Mengqian
Zhang, Lijuan
Li, Mingyue
Wei, Peijun
Yang, Yonggang
Xiao, Weikai
An, Xin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12282-021-01326-w
- URN
-
urn:nbn:de:101:1-2022070309023798473852
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yang, Anli
- Wu, Minqing
- Ni, Mengqian
- Zhang, Lijuan
- Li, Mingyue
- Wei, Peijun
- Yang, Yonggang
- Xiao, Weikai
- An, Xin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tumor microenvironment and immunotherapy for triple-negative breast cancer
RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Tumor microenvironment and immunotherapy for triple-negative breast cancer
RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Tumor microenvironment and immunotherapy for triple-negative breast cancer
RNA methylation patterns of tumor microenvironment cells regulate prognosis and immunotherapeutic responsiveness in patients with triple-negative breast cancer
Metastatic Triple-Negative Breast Cancer
TAK1 mediates microenvironment-triggered autocrine signals and promotes triple-negative breast cancer lung metastasis
Prognosis and treatment outcomes for patients with stage IA triple-negative breast cancer
COP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer
Androgen Receptor mRNA levels determine the prognosis in triple-negative breast cancer patients
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
Triple-negative and HER2-positive breast cancers found by mammography screening show excellent prognosis
Characterizing triple-negative breast cancer tumors